Clinical Trial Update: Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated thalidomide, celecoxib, and combination chemotherapy in patients with relapsed or refractory malignant glioma; the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Celecoxib (Celecoxib)
• Thalidomide (thalidomide)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED